Dai ichi Life Insurance Company Ltd cut its stake in shares of Booz Allen Hamilton Holding Co. (NYSE:BAH – Free Report) by 15.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,878 shares of the business services provider’s stock after selling 3,039 shares during the quarter. Dai ichi Life Insurance Company Ltd’s holdings in Booz Allen Hamilton were worth $2,747,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Opal Wealth Advisors LLC bought a new stake in Booz Allen Hamilton in the 2nd quarter worth approximately $26,000. OFI Invest Asset Management purchased a new stake in shares of Booz Allen Hamilton in the 2nd quarter valued at $29,000. Peterson Financial Group Inc. bought a new position in shares of Booz Allen Hamilton during the 3rd quarter valued at $31,000. Innealta Capital LLC purchased a new position in Booz Allen Hamilton in the 2nd quarter worth $34,000. Finally, Gilliland Jeter Wealth Management LLC bought a new stake in Booz Allen Hamilton in the third quarter worth $45,000. Hedge funds and other institutional investors own 91.82% of the company’s stock.
Insider Buying and Selling
In related news, CFO Matthew Calderone sold 4,065 shares of the company’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $165.00, for a total transaction of $670,725.00. Following the completion of the transaction, the chief financial officer now owns 29,618 shares in the company, valued at approximately $4,886,970. This represents a 12.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Richard Crowe sold 4,243 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $165.00, for a total value of $700,095.00. Following the transaction, the executive vice president now owns 25,496 shares of the company’s stock, valued at approximately $4,206,840. The trade was a 14.27 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 12,173 shares of company stock worth $1,989,220. 1.59% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on Booz Allen Hamilton
Booz Allen Hamilton Stock Performance
NYSE:BAH opened at $147.35 on Thursday. The stock has a 50-day simple moving average of $164.37 and a two-hundred day simple moving average of $156.80. The company has a debt-to-equity ratio of 2.76, a quick ratio of 1.56 and a current ratio of 1.56. Booz Allen Hamilton Holding Co. has a 52-week low of $123.17 and a 52-week high of $190.59. The firm has a market capitalization of $18.83 billion, a PE ratio of 23.13, a P/E/G ratio of 1.77 and a beta of 0.58.
Booz Allen Hamilton Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 4th. Stockholders of record on Friday, November 15th will be given a $0.51 dividend. The ex-dividend date is Friday, November 15th. This represents a $2.04 annualized dividend and a dividend yield of 1.38%. Booz Allen Hamilton’s payout ratio is 32.03%.
Booz Allen Hamilton Company Profile
Booz Allen Hamilton Holding Corporation provides management and technology consulting, analytics, engineering, digital solutions, mission operations, and cyber services to governments, corporations, and not-for-profit organizations in the United States and internationally. It focuses on artificial intelligence services comprising of machine learning, predictive modeling, automation and decision analytics, and quantum computing.
Featured Articles
- Five stocks we like better than Booz Allen Hamilton
- What Are the FAANG Stocks and Are They Good Investments?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Top Stocks Investing in 5G Technology
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- The Role Economic Reports Play in a Successful Investment Strategy
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Booz Allen Hamilton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Booz Allen Hamilton and related companies with MarketBeat.com's FREE daily email newsletter.